YMI and World Mental Health Day
Calgary, Alberta – October 7, 2022
For Immediate Release – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT)(OTCQB:NDATF) is pleased to announce YMI’s formal public launch will be coincident with World Mental Health Day on Monday, October 10, 2022. World Mental Health Day has been organized by the World Health Organization (“WHO”) since 2013 and this years theme is “Make mental health for all a global priority”. According to the WHO “The COVID-19 pandemic alone caused a 25% increase in the prevalence of anxiety and depression worldwide. It created “a global crisis for mental health,” while services, skills and funding for mental health “remain in short supply, and fall far below what is needed…”
The public launch includes META (“Facebook”), Search (Google), YouTube, GDN and Native Ads.
The Corporation’s Reference Database was populated during the period of April-November, 2021, a time frame in the middle of the Covid pandemic (see below), and the Corporation believes this provides YMI a unique aspect when measuring mental condition probabilities at both the current time and into the future.
Chart source: Texas Medical Centre – https://www.tmc.edu/coronavirus-updates/total-tmc-covid-19-positive-patients-in-hospital/
NDAT’s President Jim Durward states: “YMI was designed to address the high mental condition misdiagnosis rates that we believe are a root cause of the mental health crisis. As we add post-Covid data records we expect to be able to quantify the differential between a Covid-influenced population and a normal population. This differential holds the potential of further increasing YMI’s value as a tool to support objective mental condition diagnosis for individuals and therapists alike.”
YMI is available now at https://ymihealth.ca/
About nDatalyze Corp.:
nDatalyze Corp. generates technology-based, health-related solutions. The YMI division is developing a machine-learning based, online consumer mental health application with it’s database licensing division focusing on providing a specialized health-related Reference Database to application developers and researchers. YMI is based on the Corporation’s proprietary Reference Database consisting of >1200 biometric records complete with associated electroencephalogram (“EEG”) data. With installations worldwide, it’s Medxtractor division currently manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is not and accordingly the Corporation cannot accurately predict if or when YMI or it’s underlying Reference Database will become cash flow generators.
FOR FURTHER INFORMATION, PLEASE CONTACT:
James Durward, President and CEO
Telephone: (403) 689-3901
Email: [email protected] Website: www.ndatalyze.com
RBMG – RB Milestone Group LLC
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.